Effect of paroxetine on plasma vasopressin and water load testing in elderly individuals.
Hyponatremia sometimes occurs in elderly depressed patients treated wtih a serotonin reuptake inhibitor (SRI). The cause of the hyponatremia is not yet understood. The objective of this study was to determine the effects of paroxetine, an SRI, on osmoregulated release of vasopressin (also termed antidiuretic hormone) in elderly depressed patients with normal serum sodium. Four women and one man ages 61 to 74 years with a major depressive disorder were administered a water load after they had been treated with a therapeutic dose of paroxetine for 3 to 11 months. Three healthy elderly subjects not receiving paroxetine served as controls. Both the patients and the control subjects excreted > 90% of the ingested water and lowered urine osmolality to < 100 mosmol/kg. We conclude that long-term treatment with paroxetine alone does not appear to affect the ability to excrete a water load or appropriately dilute the urine during a water load (both indices of vasopressin function) in a small group of elderly patients without other risk factors for the development of hyponatremia.
Marar
I E
IE
Department of Pharmaceutical Sciences Medicine, University of Pittsburgh, Pennsylvania 15261, USA.
Towers
A L
AL
Mulsant
B H
BH
Pollock
B G
BG
Amico
J A
JA
D000368:Aged; D001127:Arginine Vasopressin / Q000097:blood*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000009:adverse effects* / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects* / Q000502:physiology
D001127:Arginine Vasopressin; D017374:Paroxetine